
The Confidence Trap in Clinical Trials: When Knowing Just Enough Becomes Dangerous
When confidence outpaces competence in clinical research, the risks can be hidden…and costly for trial sponsors

When confidence outpaces competence in clinical research, the risks can be hidden…and costly for trial sponsors

2021 was a historic year in the battle to defeat cancer. More novel cancer treatments became available than ever before with the number of Oncology

It should come as little surprise that the rise in decentralized trials (DCTs) and increase in study complexities have magnified performance demands across clinical trial

How can you minimize the performance risks given the complexities of a clinical trial and be ready to effectively conduct your next study?

Atul Mahableshwarkar, M.D., DFAPA, joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to discuss clinical trial methodology. A self-described “trial nerd,”

The area of clinical research known as CNS (central nervous system conditions) is commonly cited for its complexity and the subjective nature of many assessment

Jennifer Brandl joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to discuss the feasibility and pros and cons of virtual site

Watch on Demand Now! Clinical trials are more complex than ever. And 85% of them are delayed. More screening criteria, more procedures, new vendor systems

It’s impossible to read an industry publication without hearing about virtual clinical trials, decentralized clinical trials, or hybrid trials. Industry leaders and technology companies are

Updated 16 November 2021. The clinical operations conference landscape was nothing if not fluid in 2021, so you may be wondering what events focused on
Peju Oshisanya joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to discuss diversity and inclusion in clinical trials. An experienced clinical

If it shocks you to hear that clinical trials are getting more complex, you haven’t been paying attention. Specifically, we’re collecting more endpoints. We’re performing

By all accounts, the cost of clinical trials continues to rise. We hear reasons that include increasing protocol complexity, patient recruitment struggles, or regulatory challenges.
ArcheMedX helps life sciences and healthcare organizations to better equip, evaluate, and predict team and clinician performance
Get new original content and a hand-curated selection of the best life science articles from around the web directly in your inbox. Subscribe to The ArcheMedX Clinical Research Newsletter
See how ArcheMedX applies behavioral science to transform learning and generate actionable insights